Discover how the ARDAT consortium—uniting academia, industry, SMEs, and EFPIA members—is driving scientific and regulatory alignment to accelerate the development of Advanced Therapy Medicinal Products (ATMPs) for rare diseases.
Our flyer highlights Asphalion’s contribution to evaluating current regulatory requirements for immunogenicity assessment and immunomodulation in Gene Therapy Medicinal Products (GTMPs), as recently featured in Cell Reports Medicine.
Contact us at [email protected]
Download here:
Share
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
